Service de Pneumologie, CHU La Réunion Site Félix Guyon, Saint Denis, France
Service de Pneumologie, CHU La Réunion Site Félix Guyon, Saint Denis, France.
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00395-18. Print 2018 Jul.
is a rare species of slow-growing nontuberculous mycobacteria (NTM). From 2002 to 2017, we conducted a retrospective study that included all patients with NTM-positive respiratory samples detected in two university hospitals of the French overseas department of Reunion Island. We recorded the prevalence of in this cohort, as well as the clinical, radiological, and microbiological features of patients with at least 1 sample positive for In our cohort, 97 patients (15.1%) were positive for Twenty-one patients (21.6%) met the American Thoracic Society (ATS) criteria for infection. infection was associated with bronchiectasis, micronodular lesions, and weight loss. Antibiotic susceptibility testing was performed for 60 patients, and the isolates were found to have low susceptibility to antibiotics, except for amikacin, fluoroquinolones, and clarithromycin. Treatment failed for 4 of the 8 patients treated for infection. Here, we describe a specific cluster corresponding to a large cohort of patients with , a rare nontuberculous mycobacterium associated with low pathogenicity and poor susceptibility to antibiotics.
是一种罕见的生长缓慢的非结核分枝杆菌(NTM)。2002 年至 2017 年,我们进行了一项回顾性研究,纳入了法属留尼汪岛两个大学医院中所有分枝杆菌阳性呼吸道样本的患者。我们记录了该队列中 的流行情况,以及至少有 1 份样本分枝杆菌阳性的患者的临床、放射学和微生物学特征。在我们的队列中,97 名患者(15.1%)分枝杆菌阳性。21 名患者(21.6%)符合美国胸科学会(ATS)感染标准。分枝杆菌感染与支气管扩张、微结节病变和体重减轻有关。对 60 名患者进行了抗生素药敏试验,结果发现除阿米卡星、氟喹诺酮类和克拉霉素外,分离株对抗生素的敏感性较低。8 名接受分枝杆菌感染治疗的患者中,有 4 名治疗失败。在这里,我们描述了一个特定的集群,对应于一大群患者,这是一种罕见的非结核分枝杆菌,与低致病性和对抗生素的低敏感性有关。